The US Food and Drug Administration (FDA) has granted an extended label clearance for whole-body MRI-conditional use to Nalu Medical’s neurostimulation system under its previously cleared ...

Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved for whole-body MRI-conditional use. This clearance provides physicians ...

CARLSBAD, Calif., January 21, 2025--(BUSINESS WIRE)--Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved for whole-body ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

2-Year U.S. Treasury Note Continuous Contract $102.867-0.039-0.04% 5-Year U.S. Treasury Note Continuous Contract $106.461-0.102-0.10% 10-Year U.S. Treasury Note Continuous Contract $109.000-0.156 ...

He is past president of GAMA International, and served 8 years as NALU's National Chairman of Elections..Jack is past president of the Chicago General Agents and Managers Association, the Chicago ...